rs3802149
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003114.5(SPAG1):c.939+13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,548,334 control chromosomes in the GnomAD database, including 32,478 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2456 hom., cov: 32)
Exomes 𝑓: 0.20 ( 30022 hom. )
Consequence
SPAG1
NM_003114.5 intron
NM_003114.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.127
Publications
8 publications found
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 28Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 8-100191509-T-C is Benign according to our data. Variant chr8-100191509-T-C is described in ClinVar as Benign. ClinVar VariationId is 262804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SPAG1 | NM_003114.5 | c.939+13T>C | intron_variant | Intron 9 of 18 | ENST00000388798.7 | NP_003105.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SPAG1 | ENST00000388798.7 | c.939+13T>C | intron_variant | Intron 9 of 18 | 1 | NM_003114.5 | ENSP00000373450.3 |
Frequencies
GnomAD3 genomes AF: 0.168 AC: 25513AN: 152082Hom.: 2459 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
25513
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.199 AC: 48737AN: 245260 AF XY: 0.204 show subpopulations
GnomAD2 exomes
AF:
AC:
48737
AN:
245260
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.203 AC: 283893AN: 1396134Hom.: 30022 Cov.: 22 AF XY: 0.205 AC XY: 142912AN XY: 698032 show subpopulations
GnomAD4 exome
AF:
AC:
283893
AN:
1396134
Hom.:
Cov.:
22
AF XY:
AC XY:
142912
AN XY:
698032
show subpopulations
African (AFR)
AF:
AC:
2125
AN:
31910
American (AMR)
AF:
AC:
9189
AN:
43606
Ashkenazi Jewish (ASJ)
AF:
AC:
5812
AN:
25642
East Asian (EAS)
AF:
AC:
3131
AN:
39360
South Asian (SAS)
AF:
AC:
20739
AN:
83824
European-Finnish (FIN)
AF:
AC:
13605
AN:
53210
Middle Eastern (MID)
AF:
AC:
1371
AN:
5638
European-Non Finnish (NFE)
AF:
AC:
216283
AN:
1054668
Other (OTH)
AF:
AC:
11638
AN:
58276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
10796
21592
32388
43184
53980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7284
14568
21852
29136
36420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.168 AC: 25508AN: 152200Hom.: 2456 Cov.: 32 AF XY: 0.169 AC XY: 12589AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
25508
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
12589
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
3103
AN:
41552
American (AMR)
AF:
AC:
2753
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
791
AN:
3470
East Asian (EAS)
AF:
AC:
374
AN:
5182
South Asian (SAS)
AF:
AC:
1102
AN:
4830
European-Finnish (FIN)
AF:
AC:
2610
AN:
10564
Middle Eastern (MID)
AF:
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
AC:
14189
AN:
68006
Other (OTH)
AF:
AC:
389
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1107
2213
3320
4426
5533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
522
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 28 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.